For up to date information, videos and support resources on COVID-19 from the Psychiatry Academy, click here.
Due to the Coronavirus pandemic, our staff and faculty will be working remotely.
Please email us with any questions at or call 866-644-7792 and leave a message.


Renner, John, MD

Associate Chief of Psychiatry
Boston VA Healthcare System

Professor of Psychiatry
Boston University School of Medicine

American Psychiatric Association Council on Addiction Psychiatry


Dr. Renner is Professor of Psychiatry, Boston University School of Medicine and Associate Chief of Psychiatry, VA Boston Healthcare System. He is Vice-Chair of the American Psychiatric Association Council on Addiction Psychiatry and past President of the American Academy of Addiction Psychiatry. Dr. Renner graduated from Yale University and Case University School of Medicine. Following his psychiatry training, he served for two years in the US Navy and was Chief of Neuropsychiatry at the Naval Hospital, USS Repose, RVN. Since 1979 he has worked at the VA Boston Healthcare System where he directs their outpatient addiction treatment program. In addition, he is Director of the joint Boston University/VA Boston Addiction Psychiatry Residency and Associate Director of the Boston University Medical Center General Psychiatry Residency Program. Dr. Renner has written and lectured extensively on the treatment of alcoholism and drug addiction. He is senior editor of the American Psychiatric Association Publishing’s handbook on Office-Based Buprenorphine Treatment of Opioid Use Disorder. He is a member of the Data Safety Monitoring Board for the Clinical Trials Network of the National Institute on Drug Abuse, a member of the Clinical Advisory Committee of the Physician Health Service of the Massachusetts Medical Society, a Consultant to the Department of Psychiatry, Massachusetts General Hospital, and a member of the faculty of the Harvard Medical School Division on Addictions. He is also former medical director of the SAMHSA funded Physicians Clinical Support System-Buprenorphine.